Cbd Life Sciences Stock Cash And Equivalents

CBDL Stock  USD 0.0006  0.0001  20.00%   
Cbd Life Sciences fundamentals help investors to digest information that contributes to Cbd Life's financial success or failures. It also enables traders to predict the movement of Cbd Pink Sheet. The fundamental analysis module provides a way to measure Cbd Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cbd Life pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Cbd Life Sciences Company Cash And Equivalents Analysis

Cbd Life's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Cash

 = 

Bank Deposits

+

Liquidities

More About Cash And Equivalents | All Equity Analysis

Current Cbd Life Cash And Equivalents

    
  303.09 K  
Most of Cbd Life's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cbd Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
Competition

In accordance with the recently published financial statements, Cbd Life Sciences has 303.09 K in Cash And Equivalents. This is 99.96% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The cash and equivalents for all United States stocks is 99.99% higher than that of the company.

Cbd Cash And Equivalents Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cbd Life's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Cbd Life could also be used in its relative valuation, which is a method of valuing Cbd Life by comparing valuation metrics of similar companies.
Cbd Life is currently under evaluation in cash and equivalents category among its peers.

Cbd Fundamentals

About Cbd Life Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Cbd Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cbd Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cbd Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in Cbd Pink Sheet

Cbd Life financial ratios help investors to determine whether Cbd Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cbd with respect to the benefits of owning Cbd Life security.